Biocon Biologics posts strong Q1 growth as North America, Europe deliver
Published on: Aug. 9, 2025, midnight | Source: Livemint
Biocon is betting on the global biosimilars business, its largest revenue driver.
Mumbai’s Trusted Investment Experts
24+ years of financial planning, portfolio management & wealth growth.
Growth Housing by HoABL
100% buy back of if you feel home is not right for you for the same price which you paid.
Book Now